Alendronate Improves Bone Mineral Density in Children and Adolescents Perinatally Infected With Human Immunodeficiency Virus With Low Bone Mineral Density for Age

BACKGROUND: Children and adolescents with perinatal human immunodeficiency virus (HIV) infection and with low bone mineral density (BMD) may be at higher risk of osteoporosis and fractures in later life than their uninfected peers. Bisphosphonate therapy has been shown to reduce fractures in adults...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Infect Dis
Autori principali: Jacobson, Denise L, Lindsey, Jane C, Gordon, Catherine, Hazra, Rohan, Spiegel, Hans, Ferreira, Flavia, Amaral, Fabiana R, Pagano-Therrien, Jesica, Gaur, Aditya, George, Kathy, Benson, Jane, Siberry, George K
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Articles and Commentaries
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7442851/
https://ncbi.nlm.nih.gov/pubmed/31573608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz957
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi